Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. COVID-19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Polypharmacy in schizophrenia

    Research output: Contribution to journalReviewResearchpeer-review

  5. Pharmacokinetics of Ferric bepectate - a new intravenous iron drug for treating iron deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Determination of hepatic clearance by derivations of the indocyanine green retention test in cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Acetaminophen (APAP) is used worldwide and is regarded as safe in therapeutic concentrations but can cause acute liver failure in higher doses. High doses of APAP have been shown to inhibit complex I and II mitochondrial respiratory capacity in mouse hepatocytes, but human studies are lacking. Here, we studied mitochondrial respiratory capacity in human hepatic tissue ex vivo with increasing doses of APAP. Hepatic biopsies were obtained from 12 obese patients who underwent a Roux-en-Y gastric bypass (RYGB) or a sleeve gastrectomy surgery. Mitochondrial respiration was measured by high-resolution respirometry. Therapeutic concentrations (≤0.13 mmol/L) of APAP did not inhibit state 3 complex I-linked respiration. APAP concentrations of ≥2.0 mmol/L in the medium significantly reduced hepatic mitochondrial respiration in a dose-dependent manner. Complex II-linked mitochondrial respiration was not inhibited by APAP. We conclude that the mitochondrial respiratory capacity is affected by a hepato-toxic effect of APAP, which involved complex I, but not complex II.

Original languageEnglish
JournalBasic & clinical pharmacology & toxicology
Volume126
Issue number1
Pages (from-to)86-91
Number of pages6
ISSN1742-7843
DOIs
Publication statusPublished - Jan 2020

Bibliographical note

© 2019 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

    Research areas

  • Acetaminophen (APAP), drug-induced liver injury, hepatotoxicity, mitochondrial respiratory capacity, overdose

ID: 57797514